A5008686677- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
- Endometrial and Cervical Cancer Treatments
- Digital Radiography and Breast Imaging
- Cervical Cancer and HPV Research
- COVID-19 and healthcare impacts
- Genetic factors in colorectal cancer
- Ovarian cancer diagnosis and treatment
- Cancer Genomics and Diagnostics
- Colorectal Cancer Treatments and Studies
- Advances in Oncology and Radiotherapy
- Lung Cancer Treatments and Mutations
- Cardiac, Anesthesia and Surgical Outcomes
- BRCA gene mutations in cancer
- PARP inhibition in cancer therapy
- Radiomics and Machine Learning in Medical Imaging
- Breast Lesions and Carcinomas
- AI in cancer detection
- Digital Imaging in Medicine
- Enhanced Recovery After Surgery
- Endometriosis Research and Treatment
- Advanced X-ray and CT Imaging
- Lung Cancer Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
Azienda Sanitaria Unità Locale di Reggio Emilia
2022-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2023-2025
The aim of this study is to present the 5-year relative survival by stage breast and colorectal cancer patients in a northern Italian province. For period 2013-2015, cases were selected from Reggio Emilia Cancer Registry. Breast divided into 3 age groups: <45, 45-74 (the target screening population) 74+. Colorectal cancers classified <50, 50-69 population), over 69 years. Carcinomas situ unknown both excluded analyses. five-year was estimated using Pohar Perme method. During examined, 1,450...
Objective Lung cancer remains a highly prevalent and lethal disease, with the majority of tumors identified at advanced stages. Screening low-dose CT was shown to be effective in reducing mortality through early diagnosis. Administrative data are increasingly utilized clinical settings research for identifying metastatic lung cancer, yet their accuracy limitations require thorough evaluation. Methods This study evaluated use administrative identify metastases within population-based registry...
Ovarian cancer represents one of the most aggressive female cancers in world, remaining a tumor with high lethality. This study aims to present how multidisciplinary team (MDT) approach can improve prognosis terms recurrence and death patients. In total, 448 ovarian cases registered an Italian Cancer Registry between 2012 2020 were included. Information on age, morphology, stage, treatment was collected. Recurrence rates reported 1 2 years after diagnosis, comparing MDT vs. non-MDT...
Colorectal cancer emerged as the third most prevalent malignancy worldwide, affecting nearly 2 million individuals in year 2020. This study elucidates pivotal role of a multidisciplinary team (MDT) influencing prognosis, measured by relative survival rates, depending upon stage and age. Cases recorded an Italian Cancer Registry between 2017 2018 were included. Relative was reported at 1 3 years after diagnosis comparing MDT vs. no-MDT approaches. During period, 605 CRCs while 361 (59.7%)...
The aim of this study is to evaluate the real impact COVID-19 during entire 2020 period, compared with 2019. data comes from a Cancer Registry in Northern Italy and we clinical treatment characteristics breast cancer by age, stage, treatment, status screening. In there was no decrease invasive tumours nor situ (513 vs. 493 76 73, respectively), while significant surgery increase neoadjuvant chemotherapy (p = 0.016). screening range (aged 45–74), change stage grading observed. four periods...
This study aimed to assess the impact of a multidisciplinary team (MDT) approach on outcomes with endometrial cancer (EC) patients, utilizing 2013–2020 data from Reggio Emilia Cancer Registry. Recurrence rate, treatments, and outcome indicators were compared between MDT (319 cases) non-MDT (324 groups. Among 643 cases, 52.4% over 65 years old, 98% had microscopic confirmation, 73% in stage I. Surgery was performed 89%, 41% receiving adjuvant therapies. rates (10%) similar two groups, but...
Enhanced Recovery After Surgery (ERAS) protocols have changed perioperative care, aiming to optimize patient outcomes. This study assesses ERAS implementation effects on postoperative complications, length of hospital stay (LOS), and mortality in colorectal cancer (CRC) patients. A retrospective real-world analysis was conducted CRC patients undergoing surgery within a Northern Italian Cancer Registry. Outcomes including re-surgeries, 30-day readmission, mortality, LOS were assessed 2023,...
The COVID-19 pandemic has caused delays in cancer diagnoses and reductions treatments. aim of this work is to evaluate the impact on prostate by evaluating whether there been a shift towards more aggressive (Gleason) advanced tumors (stage IV) decline study was conducted 1123 cases incident Province Reggio Emilia, Northern Italy, period 2018-2021. In 2020, new (-31%), followed slight recovery 2021 (+5%). While Gleason 7 8-10 values remained constant, significant decrease recorded stage I...
This study aimed to assess whether multidisciplinary team (MDT) management improves outcomes in patients with stage I-III colorectal cancer (CRC) compared non-MDT care. included 460 CRC diagnosed from 2017 2018 a northern Italian province, of whom 300 (65%) were managed by MDT. MDT younger, more frequently had rectal cancers, at earlier stages, and likely undergo surgery chemotherapy. Disease-free survival (DFS) overall (OS) significantly better the group. The recurrence rate was 8.5%, no...
This study aimed to develop a multivariable, weighted overall survival (OS) risk score (SRS) for nonmetastatic (M0) invasive breast cancer (M0-BC, SRS
This study aimed to assess the incidence and patient characteristics of Endometrial cancer (EC) in an Italian Cancer Registry identify those factors that may have impact on diagnosis prognosis.The three outcomes investigated were disease-free survival (DFS), recurrence, overall (OS), by age stage Reggio Emilia province from 2013 2015.234 cases registered: over 90% 50 years old, 69% classified as I, nearly 86% had surgery, 14.5% received chemotherapy.There 21 recurrences, 10 III, 8 only 2...